Fibrotic disease and the TH1/TH2 paradigm
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, interferon-γ (IFNγ), produced by many immune cells including NK, NKT and T cells, has direct anti-fibrogenic activity on HSCs (70–72).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [71]
Experimental — accuracy not yet measuredIn the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Normally, myofibroblasts carefully coordinate the breakdown of granulation tissue and replacement with long-lasting type I collagen [100].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 1×
“However, it is now described as a general immunosuppressive cytokine that downregulates chronic inflammatory responses through many mechanism”
BackgroundAlternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Cited by
Items 701–800 of 1,000
Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis
Hikami, K., Ehara, Y., Hasegawa, M., Fujimoto, M., Matsushita, M., Oka, T., Takehara, K., Sato, S., Tokunaga, K., & Tsuchiya, N. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.054 · Cited by 41
Hu, V. H., Weiss, H. A., Ramadhani, A. M., Tolbert, S. B., Massae, P., Mabey, D. C. W., Holland, M. J., Bailey, R. L., & Burton, M. J. (2011) · Infection and Immunity · doi:10.1128/iai.05965-11 · Cited by 43
Clinical, mechanistic, and therapeutic landscape of cutaneous fibrosis
Li, D. J., Berry, C. E., Wan, D. C., & Longaker, M. T. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adn7871 · Cited by 45
Cyclosporine A Drives a Th17- and Th2-Mediated Posttransplant Obliterative Airway Disease
Lemaitre, P. H., Vokaer, B., Charbonnier, L., Iwakura, Y., Field, K. A., Estenne, M., Goldman, M., Léo, O., Remmelink, M., & Moine, A. L. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12067 · Cited by 37
Fu, Q., Yu, T., Piao, H., Du, M., & Li, D. (2014) · American Journal of Reproductive Immunology · doi:10.1111/aji.12211 · Cited by 39
Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species–Induced Mouse Model
Morin, F., Kavian, N., Nicco, C., Cerles, O., Chéreau, C., & Batteux, F. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502482 · Cited by 39
Zhang, B., Yan, C., Fan, F., Du, Y., Ma, R., Li, X., Yu, Q., Meng, D., Tang, R., & Zheng, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171005 · Cited by 37
Designer macrophages: Oxidative metabolism fuels inflammation repair
Lacy‐Hulbert, A., & Moore, K. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.001 · Cited by 51
Hoeve, M. A., Mylonas, K. J., Fairlie‐Clarke, K. J., Mahajan, S., Allen, J. E., & Graham, A. L. (2009) · BMC Immunology · doi:10.1186/1471-2172-10-60 · Cited by 39
Dendritic Cells: Novel Players in Fibrosis and Scleroderma
Lu, T. T. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-011-0215-5 · Cited by 48
Lynch, J. P., Fishbein, M. C., Saggar, R., Zisman, D. A., & Belperio, J. A. (2007) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.1.3.377 · Cited by 37
Wu, M., Sun, J., Wang, L., Wang, P., Xiao, T., Wang, S., & Liu, Q. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.130276 · Cited by 40
Di, X., Chen, J., Li, Y., Wang, M., Wei, J., Li, T., Liao, B., & Luo, D. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1545 · Cited by 46
“85 However, Th1 cells also contribute to pathological fibrosis.”
BackgroundThe IL-33 gene is related to increased susceptibility to systemic sclerosis
Koca, S. S., Pehlivan, Y., Kara, M., Alıbaz-Öner, F., Öztuzcu, S., Yilmaz, N., Çetin, G. Y., Kısacık, B., Özgen, M., Pamuk, Ö. N., et al. (2016) · Rheumatology International · doi:10.1007/s00296-015-3417-8 · Cited by 37
CXCL10-induced IL-9 promotes liver fibrosis via Raf/MEK/ERK signaling pathway
Guo, X., Cen, Y., Wang, J., & Jiang, H.-X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.128 · Cited by 39
STAT signaling in polycystic kidney disease
Strubl, S., Torres, J. A., Spindt, A. K., Pellegrini, H., Liebau, M. C., & Weimbs, T. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109639 · Cited by 36
M2 Macrophages Promote Collagen Expression and Synthesis in Laryngotracheal Stenosis Fibroblasts
Motz, K., Lina, I. A., Murphy, M. K., Drake, V. E., Davis, R. J., Tsai, H., Feeley, M., Yin, L. X., Ding, D., & Hillel, A. T. (2020) · The Laryngoscope · doi:10.1002/lary.28980 · Cited by 38
Urokinase Plasminogen Activator Induces Pro-Fibrotic/M2 Phenotype in Murine Cardiac Macrophages
Meznarich, J., Malchodi, L., Helterline, D., Ramsey, S. A., Bertko, K., Plummer, T., Plawman, A., Gold, E., & Stempien-Otero, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057837 · Cited by 36
Mizushima, I., Yamamoto, M., Inoue, D., Nishi, S., Taniguchi, Y., Ubara, Y., Matsui, S., Yasuno, T., Nakashima, H., Takahashi, H., et al. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1175-y · Cited by 28
Matsushita, Y., Hasegawa, M., Matsushita, T., Fujimoto, M., Horikawa, M., Fujita, T., Kawasuji, A., Ogawa, F., Steeber, D. A., Tedder, T. F., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.698 · Cited by 39
Vaccination-based immunotherapy to target profibrotic cells in liver and lung
Sobecki, M., Chen, J., Krzywińska, E., Nagarajan, S., Fan, Z., Nelius, E., Rodríguez, J. M. M., Seehusen, F., Hussein, A., Moschini, G., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.08.012 · Cited by 42
Metabolic signatures of immune cells in chronic kidney disease
Li, J., Yang, Y., Wang, Y., Li, Q., & He, F. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.35 · Cited by 36
Pulmonary Toxicity of Boron Nitride Nanomaterials Is Aspect Ratio Dependent
de Luna, L. A. V., Loret, T., He, Y., Légnani, M., Lin, H., Galibert, A.-M., Fordham, A., Holme, S., Castillo, A. E. D. R., Bonaccorso, F., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c06599 · Cited by 35
Animal models of airway inflammation and airway smooth muscle remodelling in asthma
Allen, J. E., Bischof, R. J., Chang, H.-Y. S., Hirota, J. A., Hirst, S. J., Inman, M. D., Mitzner, W., & Sutherland, T. E. (2009) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2009.04.001 · Cited by 38
Zhao, H., Luo, X., Zhou, Z., Liu, J., Tralau, C. J., George, A. J. T., & Ma, D. (2013) · Kidney International · doi:10.1038/ki.2013.334 · Cited by 35
ncRNA-regulated immune response and its role in inflammatory lung diseases
Xie, N., & Liu, G. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00286.2015 · Cited by 41
Oh, K., Seo, M. W., Kim, Y. W., & Lee, D. (2015) · Immune Network · doi:10.4110/in.2015.15.3.142 · Cited by 39
The Yin and Yang of Innate Lymphoid Cells in Cancer
Carrega, P., Campana, S., Bonaccorsi, I., & Ferlazzo, G. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.06.003 · Cited by 37
Grabarz, F., de Aguiar, C. F., Corrêa-Costa, M., Braga, T. T., Hiyane, M. I., Andrade‐Oliveira, V., Landgraf, M. A., & Câmara, N. O. S. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0383-7 · Cited by 37
“In addition, high levels of IL-4 were found in the BAL of patients with pulmonary fibrosis (Wynn 2004).”
BackgroundGote-Schniering, J., Benešová, M., Brunner, M., Haller, S., Cohrs, S., Frauenfelder, T., Vrugt, B., Feghali‐Bostwick, C. A., Schibli, R., Distler, O., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02724 · Cited by 39
Gremlin: a complex molecule regulating wound healing and fibrosis
O’Reilly, S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03964-x · Cited by 37
Lee, C. Y., Chooi, W. H., Ng, S., & Chew, S. Y. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10389 · Cited by 40
“Furthermore, chronic T-cell activation is shown to be involved in pathological tissue fibrosis and scarring.(37)”
BackgroundYang, M.-C., Chang, C., & Lei, H.-Y. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.139 · Cited by 35
Association of age‐dependent liver injury and fibrosis with immune cell populations
Collins, B. H., Holzknecht, Z. E., Lynn, K. A., Sempowski, G. D., Smith, C. C., Liu, S., Parker, W., & Rockey, D. C. (2013) · Liver International · doi:10.1111/liv.12202 · Cited by 37
Gauglitz, G. G., Bureik, D., Zwicker, S., Ruzicka, T., & Wolf, R. (2014) · Skin Pharmacology and Physiology · doi:10.1159/000363579 · Cited by 34
Kurotani, R., Okumura, S., Matsubara, T., Yokoyama, U., Buckley, J. R., Tomita, T., Kezuka, K., Nagano, T., Esposito, D., Taylor, T. E., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.239046 · Cited by 39
Masuda, E. K., Kommers, G. D., Martins, T. B., Barros, C. S. L., & Piazer, J. V. M. (2010) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2010.04.009 · Cited by 35
Tanabe, K., Taura, K., Koyama, Y., Yamamoto, G., Nishio, T., Okuda, Y., Nakamura, K., Toriguchi, K., Takemoto, K., Yamanaka, K., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1054-3 · Cited by 38
“By comparison, Th2 cytokines such as IL-4 and IL-13 promote activation of hepatic stellate cells and progression of liver fibrosis [16, 22, 23].”
BackgroundCharacteristic pattern of skeletal muscle remodelling in different mouse strains
Lagrota-Cândido, J., Canella, I., Pinheiro, D. F., Santos‐Silva, L. P., Ferreira, R. S., Guimarães‐Joca, F. J., Lannes-Vieira, J., & Quírico‐Santos, T. (2010) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2010.00737.x · Cited by 39
“In this context, BALB ⁄ c mice, but not C57, showed increased collagen deposition, which is in accordance with studies showing that Type2 cytokines (IL-4, IL-13 and TGF-b) cause fibroblast activation, increased collagen production and fibrosis (Wynn 2004; Mescher & Neff 2005).”
ResultBigna, J. J., Sime, P. S. D., & Koulla‐Shiro, S. (2015) · AIDS Research and Therapy · doi:10.1186/s12981-015-0078-3 · Cited by 35
Perivascular stromal cells: Directors of tissue immune niches
Sbierski‐Kind, J., Mroz, N. M., & Molofsky, A. B. (2021) · Immunological Reviews · doi:10.1111/imr.12984 · Cited by 39
p53 and Myofibroblast Apoptosis in Organ Fibrosis
McElhinney, K., Irnaten, M., & O'Brien, C. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076737 · Cited by 39
“It is estimated that in Western developed countries almost 50% of all deaths may be attributed to fibrosis [5].”
BackgroundWang, J., Lesko, M. B., Badri, M. H., Kapoor, B. C., Wu, B. G., Li, Y., Smaldone, G. C., Bonneau, R., Kurtz, Z. D., Condos, R., et al. (2017) · ERJ Open Research · doi:10.1183/23120541.00008-2017 · Cited by 41
Wang, H. Y., Li, C., Liu, W. H., Deng, F. M., Ma, Y., Guo, L. N., Kong, D. H., Hu, K. A., Liu, Q., Wu, J., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29176 · Cited by 37
“The onset and progression of LF are closely related to T‐cell‐ mediated immune responses (Pesce et al., 2006; Wynn, 2004), and the regulatory effect of MSCs on T lymphocyte proliferative capability confers them attractive candidates for antifibrotic treat- ment (Ren et al., 2008).”
BackgroundRole of 5-Lipoxygenase in IL-13-Induced Pulmonary Inflammation and Remodeling
Shim, Y. M., Zhu, Z., Zheng, T., Lee, C. G., Homer, R., Ma, B., & Elias, J. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1918 · Cited by 34
“This can be readily appreciated in recent studies that highlighted the importance of IL-13 and the impressive induction of genes that contribute to healing and scaring in type II but not in type I granulomatous responses (43, 45).”
BackgroundLorencini, M., Silva, J. A. F., Almeida, C. A., Bruni‐Cardoso, A., Carvalho, H. F., & Stach‐Machado, D. R. (2008) · Tissue and Cell · doi:10.1016/j.tice.2008.07.001 · Cited by 35
Navarro‐Partida, J., Martínez-Rizo, A. B., González-Cuevas, J., Arrevillaga-Boni, G., Ortiz-Navarrete, V. F., & Armendáriz‐Borunda, J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.025 · Cited by 37
“Th lymphocytes have an important role in the progression of fibrotic disease in several tissues including the liver (Wynn, 2004).”
BackgroundMadl, C. M., Wang, Y. X., Holbrook, C. A., Su, S., Shi, X., Byfield, F. J., Wicki, G., Flaig, I. A., & Blau, H. M. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2406787121 · Cited by 41
“Fibrosis, an excessive deposition of ECM that increases the stiffness of affected tissues, contributes to tissue dysfunction and failure in aging and disease ( 59 , 60 ).”
Lu, W., Teoh, A. K. Y., Waters, M., Haug, G., Shakeel, I., Hassan, M. I., Shahzad, A. M., Larsson‐Callerfelt, A., Piccari, L., & Sohal, S. S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108757 · Cited by 37
Altered innate immune response in farmers and smokers
Sahlander, K., Larsson, K., & Palmberg, L. (2009) · Innate Immunity · doi:10.1177/1753425909106317 · Cited by 35
The roles of chemokines in leukocyte recruitment and fibrosis in systemic sclerosis
Hasegawa, M., & Sato, S. (2008) · Frontiers in bioscience · doi:10.2741/2955 · Cited by 35
He, C., Yang, Z., Jin, Y., Qi, X., Chu, J., & Deng, X. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00657 · Cited by 39
“M2macrophage signals have been widely reported to be related to collagen deposition and ECM morphology in tissues and organs (Wynn, 2004; Wynn and Ramalingam, 2012).”
BackgroundGinsenosides: potential therapeutic source for fibrosis-associated human diseases
Li, X., Mo, N., & Li, Z. (2019) · Journal of Ginseng Research · doi:10.1016/j.jgr.2019.12.003 · Cited by 36
“It is considered that almost half of humanmortality is associated with fibrosis-associated disorder [1].”
BackgroundShabgah, A. G., Jadidi‐Niaragh, F., Mohammadi, H., Ebrahimzadeh, F., Oveisee, M., Jahanara, A., & Navashenaq, J. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.861931 · Cited by 37
“Repeated injuries, chronic inflammation, and healing are all prone to fibrosis, which occurs when fibroblasts create an abnormally large amount of ECM components, such as collagen, resulting in the formation of a permanent fibrotic scar (108, 109).”
BackgroundDing, M., Zhang, C., Wang, W., Wang, P., Pei, Y., Wang, N., Huang, S., Hao, C., & Yao, W. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115647 · Cited by 33
CB1 cannabinoid receptor antagonism: A new strategy for the treatment of liver fibrosis
Wasmuth, H. E., & Trautwein, C. (2007) · Hepatology · doi:10.1002/hep.21527 · Cited by 33
Mice lacking uteroglobin are highly susceptible to developing pulmonary fibrosis
Lee, Y., Zhang, Z., & Mukherjee, A. B. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.07.031 · Cited by 33
Renaming cytokines: MCP-1, Major Chemokine in Pancreatitis
Marra, F. (2005) · Gut · doi:10.1136/gut.2005.068593 · Cited by 33
Marquis, J.-F., Nantel, A., LaCourse, R., Ryan, L., North, R. J., & Gros, P. (2007) · Infection and Immunity · doi:10.1128/iai.00369-07 · Cited by 33
Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar
Sideek, M. A. M., Teia, A., Kopecki, Z., Cowin, A. J., & Gibson, M. A. (2015) · Journal of Molecular Histology · doi:10.1007/s10735-015-9645-0 · Cited by 37
“In the United States, fibrotic disorders have been estimated to contribute to 45 % of all-cause mortalities (Wynn 2004) and annual incidences of new cases of pulmonary fibrosis and fibrotic kidney disease have been estimated as 270/million/year (Raghu et al. 2006) and 63/million/year respectively…”
BackgroundZhang, X., Huang, Y., Luo, T., Chen, H., Li, H., Fan, X., Wang, K., Liang, J., Chen, Y., & Fan, Y. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c09890 · Cited by 33
Rajasekaran, S., Reddy, N. M., Zhang, W., & Reddy, S. P. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-381 · Cited by 34
Aging, antagonistic pleiotropy and fibrotic disease
Thannickal, V. J. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.05.010 · Cited by 32
Tassi, E., Braga, M., Longhi, R., Gavazzi, F., Parmiani, G., Carlo, V. D., & Protti, M. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007234 · Cited by 32
Loss of CDKN2B Promotes Fibrosis via Increased Fibroblast Differentiation Rather Than Proliferation
Scruggs, A. M., Koh, H. B., Tripathi, P., Leeper, N. J., White, E. S., & Huang, S. K. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0298oc · Cited by 33
Zhang, C., Zhao, H., Li, B., Fu-Gao, Liu, H., Cai, J., & Zheng, M. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.04.009 · Cited by 32
Knecht, R. S., Bucher, C. H., Linthout, S. V., Tschöpe, C., Schmidt‐Bleek, K., & Duda, G. N. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.614508 · Cited by 37
“However, a misguided immune cell response leading to a too pronounced pro-inflammatory response or a prolonged antiinflammatory response ends in an unsuccessful or delayed healing outcome (Wynn, 2004; Braga et al., 2015; Schmidt-Bleek et al., 2015; Dellacherie et al., 2019).”
BackgroundBonnard, B., Ibarrola, J., Lima-Posada, I., Fernández-Celis, A., Durand, M., Genty, M., Lopez-Andreés, N., & Jaisser, F. (2021) · HYPERTENSION · doi:10.1161/hypertensionaha.121.17712 · Cited by 28
Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis
Paola, R. D., Talero, E., Galuppo, M., Mazzon, E., Bramanti, P., Motilva, V., & Cuzzocrea, S. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-41 · Cited by 31
How Does High-Fat Diet Induce Adipose Tissue Fibrosis?
Pessin, J. E., & Kwon, H. (2012) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318271fdb9 · Cited by 36
Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection
Graham, C. S., Wells, A., Liu, T., Sherman, K. E., Peters, M. G., Chung, R. T., Bhan, A. K., Andersen, J., & Koziel, M. J. (2005) · AIDS · doi:10.1097/01.aids.0000168970.80551.3d · Cited by 32
Eosinophil activation status, cytokines and liver fibrosis in Schistosoma mansoni infected patients
Silveira-Lemos, D., Teixeira‐Carvalho, A., Martins‐Filho, O. A., Oliveira, L. F. A., Costa-Silva, M. F., Matoso, L. F., de Souza, L. J., Gazzinelli, A., & Corrêa‐Oliveira, R. (2008) · Acta Tropica · doi:10.1016/j.actatropica.2008.04.006 · Cited by 33
“…periportal fibrosis during S. mansoni infection, it has also been emonstrated that pathological fibrosis can also be associated with he chronic up-regulated production of Type-2 cytokines, IL-4 and L-13 in response to the parasite eggs in mice (Wynn, 2004) and umans (Silveira et al., 2004).”
BackgroundA two-way street - cellular metabolism and myofibroblast contraction
Noom, A., Sawitzki, B., Knaus, P., & Duda, G. N. (2024) · npj Regenerative Medicine · doi:10.1038/s41536-024-00359-x · Cited by 31
“Cardiac, lung and liver fi brosis are, for instance, responsible for 45 percent of all mortalities in the United States 1,3,4 .”
BackgroundStrategies to overcome the hurdles to treat fibrosis, a major unmet clinical need
Nanchahal, J., & Hinz, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607896113 · Cited by 35
Wen, J., Zhou, Y., Wang, J., Chen, J., Yan, W., Wu, J. S., Yan, J., Zhou, K., Xiao, Y., Wang, Y., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.31 · Cited by 31
RetractedHookworm infection is associated with decreased CD4+ T cell counts in HIV-infected adult Ugandans
Morawski, B. M., Miya, Y., Kerukadho, E., Turyasingura, G., Barbra, L., Ojok, A. M., DiNardo, A. R., Sowinski, S., Boulware, D. R., & Mejía, R. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005634 · Cited by 33
Hayward, K. L., Kouthouridis, S., & Zhang, B. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01089 · Cited by 34
Rasmussen, G. H. F., Madeleine, P., Arroyo‐Morales, M., Voigt, M., & Kristiansen, M. V. (2021) · Journal of Cancer Survivorship · doi:10.1007/s11764-021-00995-y · Cited by 31
Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars
Vanderstichèle, S., & Vranckx, J. J. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i2.200 · Cited by 36
Altered T-Cell Phenotypes in Chronic Obstructive Pulmonary Disease
Gadgil, A., Zhu, X., Sciurba, F. C., & Duncan, S. R. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200603-064ms · Cited by 31
CNS repair and axon regeneration: Using genetic variation to determine mechanisms
Tedeschi, A., Omura, T., & Costigan, M. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.004 · Cited by 34
“T-lymphocytes produce pro-inflammatory cytokines such as interferon-γ and participate in fibrosis and scarring (Wynn, 2004).”
Kidzeru, E. B., Lebeko, M., Sharma, J. R., Lucia, N., Adeola, H. A., Ndlovu, H., Khumalo, N. P., & Bayat, A. (2023) · Experimental Dermatology · doi:10.1111/exd.14734 · Cited by 30
Effects and potential mechanisms of IGF1/IGF1R in the liver fibrosis: A review
Gui, R., Li, W., Li, Z., Wang, H., Wu, Y., Jiao, W., Zhao, G., Shen, Y., Wang, L., Zhang, J., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126263 · Cited by 35
Cathepsin D is essential for the degradomic shift of macrophages required to resolve liver fibrosis
Ruiz-Blázquez, P., Fernández-Fernández, M., Pistorio, V., Martínez–Sánchez, C., Costanzo, M., Iruzubieta, P., Zhuravleva, E., Cacho-Pujol, J., Ariño, S., del Castillo-Cruz, A., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101989 · Cited by 31
“It is currently estimated that fi brosis is a contributing factor to 45% of deaths in industrialized nations [1] and it exponentially increases liver-related mortality in nonalcoholic fatty liver disease patients [2].”
BackgroundIL-17 in the Rheumatologist’s Line of Sight
Truchetet, M., Mossalayi, M. D., & Boniface, K. (2013) · BioMed Research International · doi:10.1155/2013/295132 · Cited by 32
McBride, A., Hoy, A. M., Bamford, M. J., Mossakowska, D. E., Ruediger, M. P., Griggs, J., Desai, S. D., Simpson, K., Caballero-Hernandez, I., Iredale, J. P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10521-9 · Cited by 30
Ramani, K., Tan, R. J., Zhou, D. F., Coleman, B. M., Jawale, C. V., Liu, Y., & Biswas, P. S. (2018) · Mediators of Inflammation · doi:10.1155/2018/5103672 · Cited by 33
Hirahara, K., Aoki, A., Morimoto, Y., Kiuchi, M., Okano, M., & Nakayama, T. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00735-6 · Cited by 30
Tan, Y. J., Suarez, A., Garza, M., Khan, A., Elisseeff, J. H., & Coon, D. (2020) · Biomaterials Science · doi:10.1039/c9bm00900k · Cited by 38
Inflammatory pathways in the pathogenesis of iatrogenic laryngotracheal stenosis: what do we know?
Davis, R. J., & Hillel, A. T. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.01.21 · Cited by 33
“If, however, the immunologic stimulus persists (such as an endotracheal tube causing a persistent foreign body reaction), Th2 and other regulatory cells suppress the Th1 response and promote wound healing in order to prevent excessive tissue damage by a sustained Th1 response (13).”
BackgroundInfluentialChandra, S., Ehrlich, K. C., Lacey, M. R., Baribault, C., & Ehrlich, M. (2021) · Epigenomics · doi:10.2217/epi-2020-0446 · Cited by 31
“Fibrotic disease is estimated to be responsible for almost half of the deaths in the US [1], and its far-reaching consequences extend to COVID-19’s effects on disparate tissues and organs [2].”
BackgroundMicroRNA-155 deficiency attenuates ischemia-reperfusion injury after liver transplantation in mice
Tang, B., Wang, Z., Qi, G., Yuan, S., Yu, S., Li, B., Wei, Y., Huang, Q., Zhai, R., & He, S. (2015) · Transplant International · doi:10.1111/tri.12528 · Cited by 31
Shin, J. U., Kang, S., Jeong, J. J., Nam, K., Chung, W. Y., & Lee, J. H. (2014) · Journal of Dermatological Treatment · doi:10.3109/09546634.2014.906034 · Cited by 31
Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis
Lota, H., & Renzoni, E. A. (2012) · International Journal of Rheumatology · doi:10.1155/2012/121439 · Cited by 32
Hagenlocher, Y., Satzinger, S., Civelek, M., Feilhauer, K., Köninger, J., Bischoff, S. C., & Lorentz, A. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201601085 · Cited by 34
Optimization of Sirius Red-Based Microplate Assay to Investigate Collagen Production In Vitro
Szász, C., Pap, D., Szebeni, B., Bokrossy, P., Őrfi, L., Szabo, A. J., Vannay, Á., & Veres-Székely, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417435 · Cited by 45
“It can affect almost every organ and plays an important role in various disorders, such as chronic autoimmune and inflammatory diseases, graft loss after transplantation, or atherosclerotic plaque formation, making fibrosis a contributor to 45% of deaths worldwide [1,2].”
BackgroundRusso, R. C., & Ryffel, B. (2024) · Cells · doi:10.3390/cells13242058 · Cited by 39
Wounds and the Microbiota: The Healing Interplay Between Host and Microbial Communities
Al-Taweel, R., Hammad, A. S., Tajammul, A., Crovella, S., & Al‐Asmakh, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311365 · Cited by 43
“It secretes AMPs such as β -defensins and LL-37, the lipopeptide LP78, and the serine protease inhibitor Esp, which collectively activate TLR2 signaling and stimulate LTA production [1,19,120].”
Canine visceral leishmaniasis as a systemic fibrotic disease
Silva, L. C., de Castro, R. S., Figueiredo, M. M., Michalick, M. S. M., Tafuri, W. L., & Tafuri, W. L. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12010 · Cited by 29
“Moreover, this has been strictly related to CD4+ Th2 cytokines such as IL-4, IL-5, IL-13 and IL-21 and TGFb1 (Song et al. 2000; Wynn 2004; Wick et al. 2010).”
BackgroundMatsushita, T., Date, M., Kano, M., Mizumaki, K., Tennichi, M., Kobayashi, T., Hamaguchi, Y., Hasegawa, M., Fujimoto, M., & Takehara, K. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.12.016 · Cited by 29
Metadata
- Authors
- Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Wynn, Thomas A.
- Venue
- Nature Reviews Immunology
- Published
- 2004-08
- Volume
- 4
- Issue
- 8
- Pages
- 583-594
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2702150
- OpenAlex
- W1983357763
- Cited by
- 1,765
- References
- 135
- Citations by year
- 2026: 46 · 2025: 76 · 2024: 93 · 2023: 104 · 2022: 126 · 2021: 96 · 2020: 99 · 2019: 83 · 2018: 91 · 2017: 95 · 2016: 87 · 2015: 91 · 2014: 94 · 2013: 82 · 2012: 75
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (Z01AI001019, Z01AI000829)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- fibrosis, fibrogenesis, Th1/Th2 paradigm, T helper cells, idiopathic pulmonary fibrosis, liver fibrosis, systemic sclerosis, wound healing, fibroproliferative disorders
- MeSH terms
- Animals, Fibroblasts, Fibrosis, Humans, Macrophages, Transforming Growth Factor beta, Th1 Cells, Th2 Cells, Interleukin-13, Chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.